Page 35 - Read Online
P. 35

Page 399                       Chandramohan et al. J Transl Genet Genom 2024;8:394-404  https://dx.doi.org/10.20517/jtgg.2024.38

               Table 2. Baseline characteristics and kidney biopsy findings of female patients with Fabry disease at the time of kidney biopsy
                                                                               Total
                                                       Affected    Affected focal
                No.  SCr   UPCR  CKD EPI-eGFR   2  Lyso GL-3   glomerular   glomerular   points by   Podocyte   Effacement
                                                                                                 (%)
                   (mg/dL) (g/g) (mL/min/1.73m )  (ng/mL)
                                                                               scoring
                                                                                       inclusions
                                                       sclerosis (#)  sclerosis (#)
                                                                               system
                1  0.6    0.33  106            < 5.0   N           N           3       Y         Suboptimal
                2  0.8    0.06  81             5.1     N           N           3       Y         30
                3  0.7    0.04  93             < 5.0   2           N           2       Y         > 50
                4  1.2    0.51  56             < 5.0   N           N           3       Y         < 50
                5  0.6    0.23  108            < 5.0   N           N           2       Y         50
                6  0.8    0.16  83             < 5.0   N           N           -       Y         30-50
                7  0.7    0.06  90             2.3*    1           N           2       Y         35
                8  0.7    0.12  108            < 5.0   N           N           2       Y         10
                9  0.8    0.41  105            < 5.0   1           N           -       Y         10
                10  0.8   0.12  79             5.1     N           N           2.3     Y         50
                11  0.5   0.16  130            NA      N           1           2       Y         < 50
                12  0.8   < 0.08  100          < 5.0   N           N           2       Y         75
                13  0.7   0.26  130            < 5.0   N           N           -       Y         < 10

               *detected using a newer assay, which was not available at the time of testing of the other patients. Abbreviations: SCr: Serum creatinine; UPCR:
               Urine protein/creatinine ratio; CKD EPI-eGFR: Chronic kidney disease epidemiology collaboration estimated glomerular filtration rate; Lyso GL-3:
               Globotriaosylsphingosine; Y: Yes; N: No; NA: Not available.
































                Figure 1. Light microscopy of the kidney biopsy of a female patient. The glomerulus shows swollen podocytes with finely vacuolated
                cytoplasm (yellow arrow) (H&E; x40).


               In our series, we demonstrate the presence of podocyte inclusions and foot process effacement, although the
               Lyso GL-3 levels were low, creatinine values were within the normal range, and proteinuria was minimal.
               This indicates that significant histologic damage occurs in females even with a normal or near normal
               baseline serologic evaluation. The standardized scoring system by Fogo et al. was developed using a
               modified Delphi technique combining the expertise of a panel of experts. It has been validated in female
               patients, and so we used it to grade the severity of histopathological features found on kidney biopsy. This
   30   31   32   33   34   35   36   37   38   39   40